Clinical TrialsSearch results
Number of results: 394
Not yet recruiting
- Clinical research on a neuroprotective effect of minocycline treatment in the acute stage of Ischemic Stroke
- Brain Infarction
- Takeshi Takahashi
- 2009-08-14
Other
- Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events -
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-09-10
Other
- Long-term effects of voglibose on diabetic complication in Japanese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled clinical trial
- Type 2 diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
- Impaired glucose tolerance (IGT)
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Completed
- Feasibility study of adjuvant chemotherapy with cisplatin(CDDP) and TS-1 in followed by alternate-day treatment with TS-1 in patients with completely resected pathological II-IIIA non small cell lung cancer
- Non-small cell lung cancer
- Suzuki Makoto
- 2019-03-29
Completed
- A multicenter phase II study of S-1+ramucirumab as first line treatment in elderly patients with advanced/recurrent gastric cancer(KSCC1701)
- gastric cancer
- Suyama Koichi
- 2019-03-20
Other
- Efficacy of surgery vs. radiofrequency ablation on primary hepatocellular carcinoma: a prospective cohort study
- A case without informed consent for SURF-RCT among primary hepatocellular carcinoma cases with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment
- Surgery vs. RFA (SURF) trial group
- 2009-04-01
Other
- Efficacy of surgery vs. radiofrequency ablation on primary hepatocellular carcinoma: a multicenter randomized controlled trial
- A primary hepatocellular carcinoma case with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment
- Surgery vs. RFA (SURF) trial group
- 2009-04-01